Home›Companies›Food & Agriculture›Nutrivert

Nutrivert Inc.

Develops non-antibiotic products to improve livestock health and feed efficiency for producers.

Updated Nov 10, 2026·Latest SEC filing Apr 29, 2026·Suggest an edit

About Nutrivert

Nutrivert is a private company based in Atlanta, Georgia. It has reported $3,875,266 raised in two offerings on Form D since March 2023. Its chief executive is Horace Nalle.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 10, 2026Apr 29, 2026$2,374,992of $5.9M target2$1.1MEquityRule 506(b)Form D ↗
Mar 8, 2023Mar 23, 2023$1,500,274of $2.0M target1$1.5MEquityRule 506(b)Form D ↗
Total, two offerings$3,875,266

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Nutrivert's Form D filed Apr 29, 2026.

BK
Bernhard Kaltenboeck
CSO and director
HN
Horace Nalle
CEO and director
TM
Troy Merry
Director
PS

Earlier filings also listed Jonathon Quigley (director, last listed Mar 2023).

Sources

  1. SECNutrivert Inc. filing history
  2. CompanyNutrivert about